Sanofi
42.85USD
-0.3050 (-0.71%)
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 40.6B | 41.6B | 44.3B | 46.7B | 47.7B | 50.8B |
| Q1 | — | — | — | — | 11.2B | — |
| Q2 | — | — | — | 10.7B | 12.3B | — |
| Q3 | — | — | — | 13.2B | 13.2B | — |
| Q4 | — | — | — | 12.2B | 12.5B | — |
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 2.69 | 2.15 | 2.29 | 3.19 | 5.02 | 5.42 |
| Q1 | — | — | — | — | .670 | — |
| Q2 | — | — | — | 1.62 | .145 | — |
| Q3 | — | — | — | 1.15 | 1.56 | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| — |
| -.330 |
| 1.12 |
| — |